La Jolla, CA, United States of America

Franz Meitinger

This inventor holds 1 USPTO granted patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz Meitinger. Retrieved from https://idiyas.com/inventor/franz-meitinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franz Meitinger: Innovator in Cancer Treatment

Introduction

Franz Meitinger is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of cancer research, particularly through his innovative approaches to treatment.

Latest Patents

Franz Meitinger holds a patent for "Methods of treating cancer with PLK4 inhibitors." This patent outlines compounds and methods for inhibiting PLK4, which can be utilized for treating cancer in subjects who are in need of such interventions. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Meitinger is affiliated with the Ludwig Institute for Cancer Research Limited, where he works on groundbreaking research aimed at improving cancer treatment methodologies. His work is pivotal in the ongoing fight against cancer, contributing to the development of new therapeutic strategies.

Collaborations

Throughout his career, Franz has collaborated with esteemed colleagues such as Karen Oegema and Andrew Shiau. These partnerships have fostered an environment of innovation and discovery in cancer research.

Conclusion

Franz Meitinger is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovative research in medicine. His contributions continue to inspire advancements in the field, ultimately benefiting patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…